Effects of a 12-month moderate weight loss intervention on insulin sensitivity and inflammation status in nondiabetic overweight and obese subjects

Hormone and Metabolic Research

Volumn 47, Issue 4, 2015, Pages 289-296

  Ho, T P ^a,b   Zhao, X ^a   Courville, A B ^b   Linderman, J D ^a   Smith, S ^a   Sebring, N ^b   Della Valle, D M ^b   Fitzpatrick, B ^b   Simchowitz, L ^a   Celi, F S ^a,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

inflammation; insulin sensitivity; leptin; obesity; weight loss

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; INTERLEUKIN 6; LEPTIN; LIPID;

ADULT; ANALYSIS; BLOOD; BODY COMPOSITION; BODY MASS; CALORIC RESTRICTION; CLINICAL TRIAL; DIET; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; NATIONAL HEALTH ORGANIZATION; OBESITY; PHYSIOLOGY; PROSPECTIVE STUDY; UNITED STATES; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CALORIC RESTRICTION; DIET; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; LIPIDS; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; UNITED STATES; WEIGHT LOSS;

EID: 84938552617     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1382011     Document Type: Article

References (34)

1. Lumeng C. N., Saltiel A. R. Inflammatory links between obesity and metabolic disease. J Clin Invest: 2011; 121 2111 2117
2. Maury E., Brichard S. M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol: 2010; 314 1 16
3. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol: 2005; 115 911 919 quiz 920
4. Shoelson S. E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology: 2007; 132 2169 2180
5. Hu F. B., Meigs J. B., Li T. Y., Rifai N., Manson J. E. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes: 2004; 53 693 700
6. Marques-Vidal P., Bastardot F., von Kanel R., Paccaud F., Preisig M., Waeber G., Vollenweider P. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf): 2013; 78 232 241
7. Knowler W. C., Fowler S. E., Hamman R. F., Christophi C. A., Hoffman H. J., Brenneman A. T., Brown-Friday J. O., Goldberg R., Venditti E., Nathan D. M. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet: 2009; 374 1677 1686
8. Gregg E. W., Chen H., Wagenknecht L. E., Clark J. M., Delahanty L. M., Bantle J., Pownall H. J., Johnson K. C., Safford M. M., Kitabchi A. E., Pi-Sunyer F. X., Wing R. R., Bertoni A. G. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA: 2012; 308 2489 2496
9. Ryan A. S., Nicklas B. J. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care: 2004; 27 1699 1705
10. de Mello V. D., Kolehmainen M., Pulkkinen L., Schwab U., Mager U., Laaksonen D. E., Niskanen L., Gylling H., Atalay M., Rauramaa R., Uusitupa M. Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. Diabetologia: 2008; 51 2060 2067
11. Imayama I., Ulrich C. M., Alfano C. M., Wang C., Xiao L., Wener M. H., Campbell K. L., Duggan C., Foster-Schubert K. E., Kong A., Mason C. E., Wang C. Y., Blackburn G. L., Bain C. E., Thompson H. J., McTiernan A. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res: 2012; 72 2314 2326
12. Samaropoulos X. F., Light L., Ambrosius W. T., Marcovina S. M., Probstfield J. Jr. DC. The effect of intensive risk factor management in type 2 diabetes on inflammatory biomarkers. Diabetes Res Clin Pract: 2012; 95 389 398
13. Goldfine A. B., Fonseca V., Jablonski K. A., Pyle L., Staten M. A., Shoelson S. E. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med: 2010; 152 346 357
14. Fernandez-Real J. M., Lopez-Bermejo A., Ropero A. B., Piquer S., Nadal A., Bassols J., Casamitjana R., Gomis R., Arnaiz E., Perez I., Ricart W. Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab: 2008; 93 2523 2530
15. Fleischman A., Shoelson S. E., Bernier R., Goldfine A. B. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care: 2008; 31 289 294
16. Larsen C. M., Faulenbach M., Vaag A., Volund A., Ehses J. A., Seifert B., Mandrup-Poulsen T., Donath M. Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med: 2007; 356 1517 1526
17. Stanley T. L., Zanni M. V., Johnsen S., Rasheed S., Makimura H., Lee H., Khor V. K., Ahima R. S., Grinspoon S. K. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab: 2011; 96 E146 E150
18. Goldfine A. B., Fonseca V., Shoelson S. E. Therapeutic approaches to target inflammation in type 2 diabetes. Clinical Chem: 2011; 57 162 167
19. Committee DGA Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans. Beltsville (MD): 2005
20. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obesity research: 1998; 6 02 51S 209S
21. Committee. PAGA 2008 Physical Activity Guidelines for Americans. In: Services UDoHaH ed US Govt Printing Office: 2008
22. Mifflin M. D., St Jeor S. T., Hill L. A., Scott B. J., Daugherty S. A., Koh Y. O. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr: 1990; 51 241 247
23. Yang Y. J., Youn J. H., Bergman R. N. Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol: 1987; 253 E595 E602
24. Boston R. C., Stefanovski D., Moate P. J., Sumner A. E., Watanabe R. M., Bergman R. N. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther: 2003; 5 1003 1015
25. Wallace T. M., Levy J. C., Matthews D. R. Use and abuse of HOMA modeling. Diabetes Care: 2004; 27 1487 1495
26. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 28 412 419
27. Alberti K. G., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J. C., James W. P., Loria C. M., Smith S. C. Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation: 2009; 120 1640 1645
28. Goodpaster B. H., Delany J. P., Otto A. D., Kuller L., Vockley J., South-Paul J. E., Thomas S. B., Brown J., McTigue K., Hames K. C., Lang W., Jakicic J. M. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA: 2010; 304 1795 1802
29. Ahren B., Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol: 2004; 150 97 104
30. Ziccardi P., Nappo F., Giugliano G., Esposito K., Marfella R., Cioffi M., D'Andrea F., Molinari A. M., Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation: 2002; 105 804 809
31. Balducci S., Zanuso S., Nicolucci A., Fernando F., Cavallo S., Cardelli P., Fallucca S., Alessi E., Letizia C., Jimenez A., Fallucca F., Pugliese G. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis: 2009; 20 608 617
32. Bastard J. P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab: 2000; 85 3338 3342
33. Kitabchi A. E., Temprosa M., Knowler W. C., Kahn S. E., Fowler S. E., Haffner S. M., Andres R., Saudek C., Edelstein S. L., Arakaki R., Murphy M. B., Shamoon H. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes: 2005; 54 2404 2414
34. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA: 2003; 289 1799 1804